Cornerstone National Bank & Trust’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding CDNA
AIM
FAM
ACH
BG
NAMA
Cornerstone National Bank & Trust's CDNA Position: Q1 2022 in Review
Cornerstone National Bank & Trust sold out of CareDx (CDNA) in Q1 2022, closing a stake of 5,000 shares — an estimated $227K sold.
Cornerstone National Bank & Trust first reported a position in CDNA in Q4 2021 and held it in 1 quarter. The position peaked at $227K in Q4 2021. 213 funds tracked by Wall St. Rank hold CDNA as of Q1 2022.
- Cornerstone National Bank & Trust reported no remaining CareDx position as of Q1 2022 after selling out during the quarter.
- Cornerstone National Bank & Trust sold 5,000 CareDx shares in Q1 2022, an estimated $227K.
- Cornerstone National Bank & Trust first reported a position in CareDx in Q4 2021 and held it in 1 quarter.
- Cornerstone National Bank & Trust's CareDx position peaked at $227K in Q4 2021.
- 213 funds tracked by Wall St. Rank held CareDx as of Q1 2022.
Based on Cornerstone National Bank & Trust's 13F filing for Q1 2022, filed 28 Jan 2026.